European Child & Adolescent Psychiatry

, Volume 21, Issue 10, pp 553–558 | Cite as

Individual and peer factors associated with ketamine use among adolescents in Taiwan

  • Kun-Hua Lee
  • Yi-Chun Yeh
  • Pin-Chen Yang
  • Huang-Chi Lin
  • Peng-Wei Wang
  • Tai-Ling Liu
  • Cheng-Fang YenEmail author
Original Contribution


The aim of this cross-sectional study was to examine the individual (demographic characteristics, substance-using behaviors, emotional status, and negative outcome expectancy) and peer factors associated with ketamine use in Taiwanese adolescents. A total of 9,860 adolescents completed the self-report questionnaires without omission. Demographic characteristics, substance-using behaviors, emotional status, negative outcome expectancy, and peer factors were compared between the ketamine users and non-users using the Mann–Whitney U test and the Chi-square test, and then significant factors were further selected for stepwise logistic regression analysis to examine the associated factors of ketamine use. Sixty-nine (0.7 %) participants reported having used ketamine in the past year. The results of logistic regression analysis indicated that ketamine users were more likely to use marijuana, smoke cigarettes, have peers using illicit drugs, and have a lower level of negative outcome expectancy regarding using ketamine than ketamine non-users. The associated factors found in this study should be taken into consideration when developing prevention and intervention programs for ketamine use in adolescents.


Ketamine Adolescent Psychosocial factors Risk factors 


Conflict of interest



  1. 1.
    Ns SH, Tse ML, Ng HW, Lau FL (2010) Emergency department presentation of ketamine abusers in Hong Kong: a review of 233 cases. Hong Kong Med J 16:6–11Google Scholar
  2. 2.
    Dotson JW, Ackerman DL, West LJ (1995) Ketamine abuse. J Drug Issues 25:751–757Google Scholar
  3. 3.
    Schifano F, Corkery J, Oyefeso A, Tonia T, Ghodse AH (2008) Trapped in the “K-hole” overview of deaths associated with ketamine misuse in the UK (1993–2006). J Psychopharmacol 28:114–116CrossRefGoogle Scholar
  4. 4.
    Adler CM, Malhotra AK, Elman I, Goldberg T, Egan M, Pickar D, Breier A (1999) Comparison of ketamine-induced thought disorder in healthy volunteers and thought disorder in Schizophrenia. Am J Psychiatry 156:1646–1649PubMedGoogle Scholar
  5. 5.
    Lim DK (2003) Ketamine associated psychedelic effects and dependence. Singap Med J 44:31–34Google Scholar
  6. 6.
    Dillon P, Copeland J, Jansen K (2003) Patterns of use and harms associated with non-medical ketamine use. Drug Alcohol Depend 69:23–28PubMedCrossRefGoogle Scholar
  7. 7.
    Degenhadt L, Dunn M (2008) The epidemiology of GHB and ketamine use in an Australian household survey. Int J Drug Policy 19:311–316CrossRefGoogle Scholar
  8. 8.
    Chou LC, Ho CY, Chen CY, Chen WJ (2006) Truancy and illicit drug use among adolescents survey via outreach. Addict Behav 31:149–154PubMedCrossRefGoogle Scholar
  9. 9.
    Chen WJ, Fu TC, Ting TT, Huang WL, Tang GM, Hsiao CK, Chen CY (2009) Use of ecstasy and other psychoactive substances among school-attending adolescents in Taiwan: national survey 2004–2006. BMC Public Health 9:27–34. doi: 10.1186/1471-2458-9-27 PubMedCrossRefGoogle Scholar
  10. 10.
    Engels RC, ter Bogt T (2004) Outcome expectancies and ecstasy use in visitors of rave parties in The Netherlands. Eur Addict Res 10:156–162PubMedCrossRefGoogle Scholar
  11. 11.
    Wu LT, Schlenger WE, Galvin DM (2006) Concurrent use of methamphetamine, MDMA, LSD, Ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend 84:102–113PubMedCrossRefGoogle Scholar
  12. 12.
    Yen CF, Hsu SY, Cheng CP (2007) Polysubstance use and its correlates in adolescent ecstasy users in Taiwan. Addict Behav 32:2286–2291PubMedCrossRefGoogle Scholar
  13. 13.
    Lerner RM, Castellino DR (2002) Contemporary developmental theory and adolescence: developmental systems and applied developmental science. J Adolesc Health 31:122–135PubMedCrossRefGoogle Scholar
  14. 14.
    Lankenau S, Sanders B, Bloom JJ, Hathazi D (2008) Towards an explanation of subjective ketamine experiences among young injection drug users. Addict Res Theory 16:273–287PubMedCrossRefGoogle Scholar
  15. 15.
    Huizink AC, Ferdinand RF, van den Ende J, Verhulst FC (2006) Symptoms of anxiety and depression in childhood and use of MDMA: prospective, population based study. BMJ. doi: 10.1136/bmj.38743.539398.3A PubMedGoogle Scholar
  16. 16.
    Garcia LSB, Comim CM, Valvassori SS, Réus GZ, Barbosa LM, Andreazza AC, Stertz L, Fries GR, Gavioli EC, Kapezinski F, Quevedo J (2008) Acute administration of ketamine induces antidepressant-like effects in the forced swimming test and increases BDNF levels in the rats hippocampus. Prog Neuropsychopharmacol Biol Psychiatry 32:140–144PubMedCrossRefGoogle Scholar
  17. 17.
    Galvan A, Hare T, Voss H, Glover G, Casey BJ (2007) Risk-taking and the adolescent brain: who is at risk? Dev Sci 10:8–14CrossRefGoogle Scholar
  18. 18.
    Myers R, Chou CP, Sussamn S, Baezconde-Garbanati L, Pachon H, Valente TW (2009) Acculturation and substance use: social influence as a mediator among Hispanic alternative high school youth. J Health Soc Behav 50:164–179PubMedCrossRefGoogle Scholar
  19. 19.
    Clark AE, Lohéac Y (2007) “It wasn’t me, it was them!” social influence in risky behavior by adolescents. J Health Econ 26:763–784PubMedCrossRefGoogle Scholar
  20. 20.
    Muetzlfeldt L, Kamboj SK, Rees H, Taylor J, Morgan CJA, Curran HV (2008) Journey through the K-hole: phenomenological aspects of ketamine use. Drug Alcohol Depend 95:219–229CrossRefGoogle Scholar
  21. 21.
    Yen CF, Ko CH, Yen JY, Cheng CP (2008) The multidimensional correlates associated with short nocturnal sleep duration and subjective insomnia among Taiwanese adolescents. Sleep 31:1515–1525PubMedGoogle Scholar
  22. 22.
    Ministry of the Interior (2002) Taiwan-Fukien demographic fact book, Republic of China. Executive Yuan, Taipei (in Chinese)Google Scholar
  23. 23.
    Liu TL, Yen JY, Ko CH, Huang MF, Wang PW, Yeh YC, Yen CF (2010) The associations between substances use and body mass index and the moderating effects of socio-demographic characteristics among Taiwanese adolescents. Kaohsiung J Med Sci 26:281–289PubMedCrossRefGoogle Scholar
  24. 24.
    Chien CP, Cheng TA (1985) Depression in Taiwan: epidemiological survey utilizing CES-D. Seishin Shinkeigaku Zasshi 87:335–338PubMedGoogle Scholar
  25. 25.
    Radloff LS (1977) The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas 1:385–401CrossRefGoogle Scholar
  26. 26.
    Yang HJ, Soong WT, Kuo PH, Chang HL, Chen WJ (2004) Using the CES-D in a two-phase survey for depressive disorders among nonreferred adolescents in Taipei: a stratum-specific likelihood ratio analysis. J Affect Disord 82:419–430PubMedGoogle Scholar
  27. 27.
    Faul F, Erdfelder E, Buchner A, Lang AG (2007) G*Power 3.1: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175–191PubMedCrossRefGoogle Scholar
  28. 28.
    Yen CF, Yang YH, Ko CH, Yen JY (2005) Substance initiation sequences among Taiwanese adolescents using methamphetamine. Psychiatry Clin Neurosci 59:683–689PubMedCrossRefGoogle Scholar
  29. 29.
    Joe-Laidler K, Hunt G (2008) Sit down to float: the culture meaning of ketamine use in Hong Kong. Addict Res Theory 16:259–271PubMedCrossRefGoogle Scholar
  30. 30.
    Maddahian E, Newcomb MD, Bentler PM (1988) Adolescent drug use amon intention to use drugs: concurrent and longitudinal analyses of four ethnic groups. Addict Behav 13:191–195PubMedCrossRefGoogle Scholar
  31. 31.
    White B, Degenhardt L, Breen C, Bruno R, Newman J, Proudfoot P (2006) Risk and benefit perceptions of party drug use. Addict Behav 31:137–142PubMedCrossRefGoogle Scholar
  32. 32.
    Katz EC, Fromme K, D’Amico EJ (2000) Effects of outcome expectancies and personality on young adults’ illicit drug use, heavy drinking, and risky sexual behavior. Cognit Therapy Res 24:1–22CrossRefGoogle Scholar
  33. 33.
    Vangsness L, Bry BH, LaBouvie EW (2005) Impulsivity, negative expectancies, and marijuana use: a test of the acquired preparedness model. Addict Behav 30:1071–1076PubMedCrossRefGoogle Scholar
  34. 34.
    Price RB, Nock MK, Charney DS, Mathew SJ (2009) Effects of Intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66:522–526. doi: 10.1016/j.biopsych.2009.04.029 PubMedCrossRefGoogle Scholar
  35. 35.
    Oei TPS, Morawska A (2004) A cognitive model of binge drinking: the influence of alcohol expectancies and drinking refusal self-efficacy. Addict Behav 29:159–179PubMedCrossRefGoogle Scholar
  36. 36.
    Webb TL, Sheeran P (2006) Does changing behavioral intentions engender behavior change? A meta-analysis of the experimental evidence. Psychol Bull 132:249–268PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2012

Authors and Affiliations

  • Kun-Hua Lee
    • 1
  • Yi-Chun Yeh
    • 2
    • 3
  • Pin-Chen Yang
    • 2
    • 3
  • Huang-Chi Lin
    • 2
    • 3
  • Peng-Wei Wang
    • 2
    • 3
  • Tai-Ling Liu
    • 2
    • 3
  • Cheng-Fang Yen
    • 2
    • 3
    Email author
  1. 1.Institute of Allied Health Sciences, College of MedicineNational Cheng Kung UniversityTainanTaiwan
  2. 2.Department of PsychiatryKaohsiung Medical University HospitalKaohsiungTaiwan
  3. 3.Department of Psychiatry, Faculty of Medicine, College of MedicineKaohsiung Medical UniversityKaohsiungTaiwan

Personalised recommendations